Correction to: Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study
High Blood Press Cardiovasc Prev. 2023 Sep;30(5):487.
doi: 10.1007/s40292-023-00599-w.
1 Department of Clinical Medicine, Public Health, Life and Environmental Sciences, University of L'Aquila, 67100, L'Aquila, Italy. rita.delpinto@univaq.it.
2 Internal Medicine and Nephrology Unit, ESH Excellence Center for Hypertension and Cardiovascular Prevention, San Salvatore Hospital, 67100, L'Aquila, Italy. rita.delpinto@univaq.it.
3 Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. rita.delpinto@univaq.it.
4 Società Italiana Farmacia Clinica (SIFAC), Cagliari, Italy.
5 Medical Affairs, Servier Italia, Rome, Italy.
6 Department of Clinical Medicine, Public Health, Life and Environmental Sciences, University of L'Aquila, 67100, L'Aquila, Italy.
7 Internal Medicine and Nephrology Unit, ESH Excellence Center for Hypertension and Cardiovascular Prevention, San Salvatore Hospital, 67100, L'Aquila, Italy.